AngioDynamics to Host Investor and Analyst Day on January 23, 2013

ALBANY, N.Y., Jan. 15, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will host an investor and analyst meeting on Wednesday, January 23, 2013, to discuss AngioDynamics' long-term growth strategy, research and development pipeline, and financial outlook. The day will also include a technology fair and product demonstrations.

The program will include presentations by AngioDynamics' President and Chief Executive Officer Joseph DeVivo and Executive Vice President and Chief Financial Officer Mark Frost, as well as presentations and question and answer with members of the senior management team.

Advanced registration is required, and attendance will be limited to institutional investors and equity research analysts who register in advance. To register for the meeting, please contact the Company's Investor Relations: Greg Gin of EVC Group, Inc. at ggin@evcgroup.com.

A live webcast will be available at http://investors.angiodynamics.com. A replay and the presentation materials will be available at the same website following the conclusion of the meeting.

About AngioDynamics

AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.


AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.

CONTACT: Company Contact: AngioDynamics, Inc. Mark Frost, CFO (800) 772-6446 x1981 mfrost@AngioDynamics.com Investor Relations Contacts: EVC Group, Inc. Greg Gin/Robert Jones (646) 445-4801; (646) 201-5447 ggin@evcgroup.com; bjones@evcgroup.com Media Contact: EVC Group, Inc. Chris Gale (646) 201-5431 cgale@evcgroup.comSource:AngioDynamics